Skip to content

Genetic and Functional Analysis of Aplasia Cutis Congenital (ACC)

Identification of Mutations That Lead to Aplasia Cutis Congenita in Families and Isolated Cases and Studies of Cellular and Molecular Mechanisms

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01630421
Acronym
ACC
Enrollment
600
Registered
2012-06-28
Start date
2009-04-01
Completion date
2030-12-01
Last updated
2026-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aplasia Cutis Congenita

Keywords

Aplasia cutis congenita, bone, osteoblast, osteoclast, skin

Brief summary

The goal of this research study is to identify genes and regulatory elements on chromosomes that cause ACC. The investigators also study tissue samples from patients to learn about the processes that lead to this disorder.

Detailed description

Aplasia cutis congenita (ACC) or congenital scalp defect is a very rare disorder that affects bone and skin. The definition for ACC is the localized absence of (normal) skin at the time of birth (congenital). The skin appears thinner and the underlying structures are visible. We study mostly the isolated form of ACC with the lesion often being at the vertex of the skull (at or close to the top of the skull). The bone underlying the lesion is sometimes thinner as well. For this study we will: * Send out study participation kits and consent by phone * Collect a saliva sample from eligible individuals * Obtain information regarding ACC * Document disorder with photos and doctor's letters * If patients undergo surgery for ACC we ask to obtain some tissue that would otherwise be discarded * Isolate DNA from the saliva sample * Perform genetic analyses of the DNA with the most up-to-date methods available to identify genetic variations * Study in the laboratory why the genetic variations cause the disorder

Interventions

None listed

Sponsors

UConn Health
Lead SponsorOTHER

Study design

Observational model
FAMILY_BASED
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* ACC; unaffected individuals only if part of a participating ACC family

Exclusion criteria

* No ACC unaffected individuals only as part of a participating ACC family

Design outcomes

Primary

MeasureTime frameDescription
Identification of genetic elementsat time of identificationThe goal is to identify relevant genes or genetic elements that cause the disease or contribute to the disease progression and severity.

Countries

United States

Contacts

CONTACTErnst J Reichenberger, PhD
reichenberger@uchc.edu860-679-2062
PRINCIPAL_INVESTIGATORErnst J Reichenberger, PhD

UConn Health

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 16, 2026